Introduction
Anti-mitochondial antibodies are found in over 95% of patients with primary biliary cirrhosis and are routinely detected by immunofluorescence. ' The mitochondrial antigens are components of the mitochondrial 2-oxo acid dehydrogenase complex (M2 complex), and antibodies to these antigens can be detected by immunoblotting.2 Two patients with Graves' disease and positive anti-mitochondrial antibodies were identified. Neither patient had evidence of liver disease which prompted us to follow their serum titres to anti-mitochondrial antibodies serially and study their antibody reactivity to the purified antigens.
Materials and methods
Anti-mitochondrial antibodies were measured by immunofluorescence and by immunoblotting as described previously.2
Results
Patient 1 was a 14 year old female with Graves' disease. Anti-mitochondrial antibodies were absent at presentation, present at 2 years (titre 1:40), 4 years (titre 1:20) but absent at 6 years.
Patient 2 was a 48 year old female with Graves' disease. Anti-mitochondrial antibodies were detec-the purified M2 complex by immunoblotting was absent in both patients' sera ( Figure 1 ).
Discussion
Anti-mitochondrial antibodies are detected routinely by immunofluorescence, which is highly specific for identifying patients with primary biliary cirrhosis.' Patients with primary biliary cirrhosis whose sera are positive for anti-mitochondrial antibodies by immunofluorescence but negative against the M2 complex by immunoblotting are extremely rare, and usually associated with abnormal serum biochemical liver tests. 3 The absence of liver dysfunction in the cases reported here, combined with the lack of serum reactivity against the M2 antigens by immunoblotting, suggests that they did not have primary biliary cirrhosis. Patients with autoimmune thyroid disease may produce antibodies to the mitochondrial ATP/ADP transporter protein,4 and it is possible that our patients possessed such antibodies.
Primary biliary cirrhosis is associated with autoimmune thyroid disease, and anti-mitochondrial antibodies in patients with Graves' disease have been described.5 However, positive anti-mitochondrial antibodies by immunofluorescence in patients with autoimmune thyroid disease do not necessarily signify the presence of subclinical primary biliary cirrhosis. Testing such sera against the M2 antigens by immunoblotting may be a useful means of resolving this problem. 
